Show Parent

January

The ERJ in its 21st year of age: a smooth transition for an everlasting evolution Dinh-Xuan A. T., Brusasco V. Eur Respir J 2009; 33: 1-2
Safety of long-acting β-agonists: urgent need to clear the air remains Beasley R., Martinez F. D., Hackshaw A., Rabe K. F., Sterk P. J., Djukanovic R. Eur Respir J 2009; 33: 3-5
Pulmonary infiltrates in patients with malignancies: why and how neutropenia influences clinical reasoning Azoulay E. Eur Respir J 2009; 33: 6-8
From surgical to molecular scalpel: ERJ lung cancer series for 2009 Brambilla C. Eur Respir J 2009; 33: 9-10
Asthma therapy: how far have we come, why did we fail and where should we go next? Janssen L. J. Eur Respir J 2009; 33: 11-20
Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials Sears M. R., Ottosson A., Radner F., Suissa S. Eur Respir J 2009; 33: 21-32
Dietary patterns and asthma in the E3N study Varraso R., Kauffmann F., Leynaert B., Le Moual N., Boutron-Ruault M. C., Clavel-Chapelon F., Romieu I. Eur Respir J 2009; 33: 33-41
Cysteinyl leukotriene receptor 1 gene variation and risk of asthma Hong X., Zhou H., Tsai H-J., Wang X., Liu X., Wang B., Xu X., Xu X. Eur Respir J 2009; 33: 42-48
Paradoxical movement of the lower ribcage at rest and during exercise in COPD patients Aliverti A., Quaranta M., Chakrabarti B., Albuquerque A. L. P., Calverley P. M. Eur Respir J 2009; 33: 49-60
Decreased FOXP3 expression in small airways of smokers with COPD Isajevs S., Taivans I., Strazda G., Kopeika U., Bukovskis M., Gordjusina V., Kratovska A. Eur Respir J 2009; 33: 61-67
Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia Park I. N., Jegal Y., Kim D. S., Do K-H., Yoo B., Shim T. S., Lim C-M., Lee S. D., Koh Y., Kim W. S., Kim W. D., Jang S. J., Kitaichi M., Nicholson A. G., Colby T. V. Eur Respir J 2009; 33: 68-76
MMP expression and abnormal lung permeability are important determinants of outcome in IPF McKeown S., Richter A. G., O'Kane C., McAuley D. F., Thickett D. R. Eur Respir J 2009; 33: 77-84
Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study van Gent M. W. F., Post M. C., Luermans J. G. L. M., Snijder R. J., Westermann C. J. J., Plokker H. W. M., Overtoom T. T., Mager J. J. Eur Respir J 2009; 33: 85-91
Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension Degano B., Yaici A., Le Pavec J., Savale L., Jais X., Camara B., Humbert M., Simonneau G., Sitbon O. Eur Respir J 2009; 33: 92-98
Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis Troosters T., Langer D., Vrijsen B., Segers J., Wouters K., Janssens W., Gosselink R., Decramer M., Dupont L. Eur Respir J 2009; 33: 99-106
Lung structure and function of infants with recurrent wheeze when asymptomatic Llapur C. J., Martinez T. M., Coates C., Tiller C., Wiebke J. L., Li X., Applegate K., Coxson H. O., Tepper R. S. Eur Respir J 2009; 33: 107-112
Sniff nasal inspiratory pressure in children with muscular, chest wall or lung disease Fauroux B., Aubertin G., Cohen E., Clement A., Lofaso F. Eur Respir J 2009; 33: 113-117
Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival Ohri C. M., Shikotra A., Green R. H., Waller D. A., Bradding P. Eur Respir J 2009; 33: 118-126
Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications Mohamed S., Yasufuku K., Nakajima T., Hiroshima K., Chiyo M., Yoshida S., Suzuki M., Sekine Y., Shibuya K., Agamy G., El-Shahhat H., Fujisawa T., Yoshino I. Eur Respir J 2009; 33: 127-133
High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation Sheen P., O'Kane C. M., Chaudhary K., Tovar M., Santillan C., Sosa J., Caviedes L., Gilman R. H., Stamp G., Friedland J. S. Eur Respir J 2009; 33: 134-141
The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia Aliberti S., Myers J. A., Peyrani P., Blasi F., Menendez R., Rossi P., Cosentini R., Lopardo G., de Vedia L., Ramirez J. A. Eur Respir J 2009; 33: 142-147
Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease Santin M., Dorca J., Alcaide F., Gonzalez L., Casas S., Lopez M., Guerra M. R. Eur Respir J 2009; 33: 148-152
Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Restrepo M. I., Mortensen E. M., Waterer G. W., Wunderink R. G., Coalson J. J., Anzueto A. Eur Respir J 2009; 33: 153-159
Recurrence of tuberculosis in a low-incidence setting Dobler C. C., Crawford A. B. H., Jelfs P. J., Gilbert G. L., Marks G. B. Eur Respir J 2009; 33: 160-167
Reversing the tuberculosis upwards trend: a success story in Romania Marica C., Didilescu C., Galie N., Chiotan D., Zellweger J. P., Sotgiu G., D'Ambrosio L., Centis R., Ditiu L., Migliori G. B. Eur Respir J 2009; 33: 168-170
Long-term macrolide therapy in chronic inflammatory airway diseases Crosbie P. A. J., Woodhead M. A. Eur Respir J 2009; 33: 171-181
Animal models of ventilator-associated pneumonia Luna C. M., Sibila O., Agusti C., Torres A. Eur Respir J 2009; 33: 182-188
Pulmonary veno-occlusive disease Montani D., Price L. C., Dorfmuller P., Achouh L., Jais X., Yaici A., Sitbon O., Musset D., Simonneau G., Humbert M. Eur Respir J 2009; 33: 189-200
Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration De Wever W., Stroobants S., Coolen J., Verschakelen J. A. Eur Respir J 2009; 33: 201-212
Pulmonary veno-occlusive disease in myeloproliferative disorder Willems E., Canivet J-L., Ghaye B., de Leval L., Radermecker M., Preiser J-C., Beguin Y. Eur Respir J 2009; 33: 213-216
Animal models of airway hyperresponsiveness Said S. I. Eur Respir J 2009; 33: 217-218
Are asymptomatic airway hyperresponsiveness and allergy risk factors for asthma? A longitudinal study Rage E., Siroux V., Le Moual N., Pin I., Kauffmann F. Eur Respir J 2009; 33: 218-219
Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema Cottin V., Fabien N., Khouatra C., Moreira A., Cordier J-F. Eur Respir J 2009; 33: 219-221
Pre-immigration screening for pulmonary tuberculosis: the unanswered questions Bhuniya S. Eur Respir J 2009; 33: 221-222
"CAN CAP GUIDELINE ADHERENCE IMPROVE PATIENT OUTCOME IN INTERNAL MEDICINE DEPARTMENTS?". F. BLASI, I. IORI, A. BULFONI, S. CORRAO, S. COSTANTINO AND D. LEGNANI. EUR RESPIR J 2008; 32: 902-910. Eur Respir J 2009; 33: 223
"THE LEICESTER COUGH MONITOR: A SEMI-AUTOMATED, SEMI-VALIDATED COUGH DETECTION SYSTEM?". S.S. BIRRING, V.M. MANN, S. MATOS, N. YOUSAF, C. WOOD, T. FLEMING, D.H. EVANS, A.H. MORICE AND I.D. PAVORD. EUR RESPIR J 2008; 32: 530-531. Eur Respir J 2009; 33: 224
Asthma Gaga M. Eur Respir J 2009; 33: 225